Form 4 for APYX Apyx Medical Corp
Accepted 2022-07-11 00:00:00 ET · period of report 2022-07-06 · accession 0000719135-22-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-11 | 2022-07-06 | APYX | Geraghty Michael | Dir | M - OptEx | $2.54 | +4,000 | 17.5K | +30% | +$10.2K |
| D | 2022-07-11 | 2022-07-06 | APYX | Geraghty Michael | Dir | M - OptEx | $0.00 | -4,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-06 | M | A | 4,000 | $2.54 | 17,500 | D | — | — | |
| 2 | Derivative | Stock Option (Option to Buy) | 2022-07-06 | M | D | 4,000 | $0.00 | 0 | D | $2.54 · 2013-07-12 to 2022-07-12 | 4,000 Common Stock | (F1) Reporting Person was granted a stock option that vested and became exercisable over 3 years at a rate of 33.33% of the option on the anniversary date of each succeeding year. |